Breast Cancer Diagnostics Market to Grow Rapidly at a CAGR of 8.7% by 2030 | DataM Intelligence
The Global Breast Cancer Diagnostics Market was valued at US$ 4.1 billion in 2022 and is expected to reach US$ 7.9 billion by 2030
New York, Aug. 04, 2023 (GLOBE NEWSWIRE) — The Global Breast Cancer Diagnostics Market was valued at US$ 4.1 billion in 2022 and is expected to reach US$ 7.9 billion by 2030, exhibiting a CAGR of 8.7% during the forecast period (2023-2030).
The breast cancer diagnostics market is a crucial and rapidly evolving segment of the healthcare industry focused on the early detection, diagnosis, and monitoring of breast cancer, one of the most prevalent and life-threatening cancers affecting women worldwide.
With continuous advancements in technology, increased awareness about breast cancer screening, and a growing emphasis on personalized medicine, the breast cancer diagnostics market is witnessing significant growth and is poised to have a profound impact on breast cancer care and treatment.
Key players operating in the global breast cancer diagnostics market include Smith & Nephew PLC, Molnlycke Health Care Ab, Baxter International Inc, Acelity L.P. Inc., Integra Lifesciences Holding Corporation, Coloplast A/S, Ethicon Inc, 3M, Paul Hartmann AG, and Convatec Group.
Key Developments in the Global Breast Cancer Diagnostics Market
In May 2023, Siemens Healthineers launched the Mammobionic AI system, a new artificial intelligence-powered system that can help to improve the accuracy of mammograms.
In April 2023, Danaher launched the Pathwa Dx breast cancer test, a new liquid biopsy test that can be used to detect breast cancer in women with dense breasts.
In March 2023, Siemens Healthineers acquired Athena Diagnostics for $1.1 billion.
|Data Availability||Value (USD)|
|Segments Covered||By Diagnostic Technique, By End Users, and By Region|
|Regions Covered||North America, Europe, Asia-Pacific, Latin America and Middle East & Africa|
|Fastest Growing Region||Asia-Pacific|
|Largest Region||North America|
|Report Insights Covered||Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other Key insights.|
To get more insights into the Global Breast Cancer Diagnostics Market Report Click here: https://www.datamintelligence.com/download-sample/breast-cancer-diagnostics-market
Breast Cancer Diagnostics Market: Overview
Breast cancer is one of the most common types of cancer affecting women worldwide, and early detection is crucial for successful treatment and improved patient outcomes. Diagnostic methods for breast cancer include imaging techniques, such as mammography, ultrasound, and magnetic resonance imaging (MRI), which help identify suspicious lesions or abnormalities in breast tissue.
Moreover, biopsies, either through fine-needle aspiration, core needle biopsy, or surgical biopsy, are performed to obtain tissue samples for definitive diagnosis and to determine the cancer’s type, grade, and hormone receptor status.
Breast Cancer Diagnostics Market: Opportunities
The increasing prevalence of breast cancer globally, coupled with growing awareness about the importance of early detection and screening, is boosting the demand for advanced diagnostic technologies.
Moreover, technological advancements in breast imaging, such as digital mammography, breast tomosynthesis, and molecular breast imaging, offer more accurate and efficient detection of breast abnormalities, fueling market growth.
Breast Cancer Diagnostics Market: Dynamics
The rising incidence of breast cancer globally is a major driver of the market. Breast cancer remains one of the most common cancers affecting women, and its incidence is increasing, not only in developed countries but also in emerging economies. As breast cancer rates continue to climb, the demand for accurate and efficient diagnostic tools becomes increasingly crucial in early detection and improved treatment outcomes.
Moreover, technological advancements in breast cancer diagnosis are significantly contributing to market growth. Medical imaging technologies, such as digital mammography, ultrasound, magnetic resonance imaging (MRI), and breast tomosynthesis, have undergone substantial improvements, enabling more precise and earlier detection of breast abnormalities.
Breast Cancer Diagnostics Market: Geographical Insights
North America held a dominant position in the breast cancer diagnostics market in 2021. This is owing to the increasing prevalence of breast cancer cases and the rising technological advancements in the region.
For a Customized Report Click Here: https://www.datamintelligence.com/customize/breast-cancer-diagnostics-market
Table of Contents
|1||Report Methodology and Scope|
|2||Report Definition and Overview|
|7||Breast Cancer Diagnostics Market Segments and Region|
|8||Global Company Share Analysis – 10 Key Companies|
|9||Breast Cancer Diagnostics Market Company and Product Profiles|
Ovarian Cancer Diagnostics Market
Liver Cancer Diagnostics Market
Prostate Cancer Diagnostics Market
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
CONTACT: Sai Kiran Sales Manager at DataM Intelligence Email: [email protected] Tel: +1 877 441 4866 Website: www.datamintelligence.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.